Add like
Add dislike
Add to saved papers

Nine New Triterpene Glycosides, Magnumosides A₁-A₄, B₁, B₂, C₁, C₂ and C₄, from the Vietnamese Sea Cucumber Neothyonidium (=Massinium) magnum: Structures and Activities against Tumor Cells Independently and in Synergy with Radioactive Irradiation.

Marine Drugs 2017 August 17
Nine new sulfated triterpene glycosides, magnumosides A₁ ( 1 ), A₂ ( 2 ), A₃ ( 3 ), A₄ ( 4 ), B₁ ( 5 ), B₂ ( 6 ), C₁ ( 7 ), C₂ ( 8 ) and C₄ ( 9 ) as well as a known colochiroside B₂ ( 10 ) have been isolated from the tropical Indo-West Pacific sea cucumber Neothynidium (= Massinium ) magnum (Phyllophoridae, Dendrochirotida) collected in the Vietnamese shallow waters. The structures of new glycosides were elucidated by 2D NMR spectroscopy and mass-spectrometry. All the isolated new glycosides were characterized by the non-holostane type lanostane aglycones having 18(16)-lactone and 7(8)-double bond and differed from each other by the side chains and carbohydrate moieties structures. Magnumoside A₁ ( 1 ) has unprecedented 20(24)-epoxy-group in the aglycone side chain. Magnumosides of the group A ( 1 - 4 ) contained disaccharide monosulfated carbohydrate moieties, of the group B ( 5 , 6 )-tetrasaccharide monosulfated carbohydrate moieties and, finally, of the group C ( 7 - 9 )-tetrasaccharide disulfated carbohydrate moieties. The cytotoxic activities of the compounds 1 - 9 against mouse spleen lymphocytes, the ascites form of mouse Ehrlich carcinoma cells, human colorectal carcinoma DLD-1 cells as well as their hemolytic effects have been studied. Interestingly, the erythrocytes were more sensitive to the glycosides action than spleenocytes and cancer cells tested. The compounds 3 and 7 significantly inhibited the colony formation and decreased the size of colonies of DLD-1 cancer cells at non-cytotoxic concentrations. Moreover, the synergism of effects of radioactive irradiation and compounds 3 and 7 - 9 at subtoxic doses on proliferation of DLD-1 cells was demonstrated.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app